This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Concise guidance on identifying budgeting flaws early and applying simple corrections to avoid debt and build security.
24,706 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
As Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
AI can save workers time, but a leadership gap risks translating that advantage into real value. Here’s what the late...
Grayscale Research outlines a bull case for AAVE, arguing regulatory clarity could push its fair value toward $175 wi...
A legal fight over a listing rule has spiraled into concerns about privacy and governance inside the National Associa...
Archer Aviation counters Jobs, accusing Joby of government misrepresentation and hidden foreign ties. The ongoing dis...
Ripple (XRP) traders are eyeing a potential return to its 2025 peak of $3.65, even as the token trades near $1.45. Ke...
Britain’s Financial Conduct Authority added Hyperliquid and the Hyper Foundation to its warning list on May 21, citin...
As copper markets gyrate in 2026, investors must choose between COPX miners and CPER futures for exposure. The decisi...
The AI boom has cooled, but the backbone of AI—data centers and cloud services—remains essential. This guide highligh...
Investors are placing bets on Boeing’s turnaround amid ongoing quality concerns and fresh defense contracts. The stoc...
Apple reveals a staggering pay gap in its 2025 proxy, with CEO compensation at roughly $74 million vs. a median emplo...